IP Verse

Symbiosis Ip Limited competitive analysis

Explore patent oppositions filed by Symbiosis Ip Limited against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 17, 2026

Patent Number	Title	Applicant	Opposition Date
EP3498734	Combination Of A Pd-1 Antagonist And A Vegfr Inhibitor For Treating Cancer	MERCK SHARP & DOHME	May 26, 2022
EP3283882	Blood-Based Biomarkers Of Tumor Sensitivity To Pd-1 Antagonists	MERCK SHARP & DOHME	Sep 15, 2021

Discover the latest PTAB cases involving Symbiosis Ip Limited, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Symbiosis Ip Limited with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 17, 2026

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
SYMBIOSIS IP LIMITED	2	-	-	-
MERCK SHARP & DOHME	26	56	61	5
PFIZER	76	117	44	12